Telomir Pharmaceuticals Inc (TELO)

Currency in USD
1.50
+0.05(+3.45%)
Closed·
1.51+0.01(+0.67%)
·
TELO Scorecard
Full Analysis
Suffers from weak gross profit margins
Earnings results expected in 12 days
TELO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.431.51
52 wk Range
1.128.40
Key Statistics
Prev. Close
1.5
Open
1.46
Day's Range
1.43-1.51
52 wk Range
1.12-8.4
Volume
161.81K
Average Volume (3m)
3.18M
1-Year Change
-72.43%
Book Value / Share
0.02
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TELO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Telomir Pharmaceuticals Inc Company Profile

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on reversing biological aging and degenerative diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Progeria, Wilson’s disease, and age-related macular degeneration (amd), as well as type 2 diabetes, cancer, and Alzheimer’s disease. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.

Compare TELO to Peers and Sector

Metrics to compare
TELO
Peers
Sector
Relationship
P/E Ratio
−3.0x−0.5x−0.6x
PEG Ratio
−0.160.100.00
Price/Book
100.6x2.2x2.6x
Price / LTM Sales
-1.7x3.3x
Upside (Analyst Target)
-162.5%40.0%
Fair Value Upside
Unlock13.0%4.7%Unlock

Earnings

Latest Release
May 28, 2025
EPS / Forecast
-0.07 / -0.06
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

TELO Income Statement

People Also Watch

47.73
BMNR
-8.32%
14.9500
INKT
+3.32%
5.60
REPL
+6.67%
20.06
SRPT
-2.53%
3.600
OPEN
+11.80%

FAQ

What Stock Exchange Does Telomir Pharmaceuticals Trade On?

Telomir Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Telomir Pharmaceuticals?

The stock symbol for Telomir Pharmaceuticals is "TELO."

What Is the Telomir Pharmaceuticals Market Cap?

As of today, Telomir Pharmaceuticals market cap is 48.10M.

What Is Telomir Pharmaceuticals's Earnings Per Share (TTM)?

The Telomir Pharmaceuticals EPS (TTM) is -0.54.

When Is the Next Telomir Pharmaceuticals Earnings Date?

Telomir Pharmaceuticals will release its next earnings report on 02 Sept 2025.

From a Technical Analysis Perspective, Is TELO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Telomir Pharmaceuticals Stock Split?

Telomir Pharmaceuticals has split 0 times.

How Many Employees Does Telomir Pharmaceuticals Have?

Telomir Pharmaceuticals has 0 employees.

What is the current trading status of Telomir Pharmaceuticals (TELO)?

As of 22 Aug 2025, Telomir Pharmaceuticals (TELO) is trading at a price of 1.50, with a previous close of 1.50. The stock has fluctuated within a day range of 1.43 to 1.51, while its 52-week range spans from 1.12 to 8.40.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.